Related Experiment Videos
What did we learn from 'omics' studies in osteoarthritis
Cristina Ruiz-Romero1,2, Ignacio Rego-Perez3,4, Francisco J Blanco1,3,4
1Rheumatology Division, ProteoRed/ISCIII Proteomics Group, INIBIC - Hospital Universitario de A Coruña.
Current Opinion in Rheumatology
|October 17, 2017
Summary
Omics technologies have advanced osteoarthritis research, identifying numerous potential biomarkers. Further validation in large patient groups and integrated data analysis are crucial for clinical application.
Area of Science:
- Biochemistry
- Genomics
- Proteomics
- Metabolomics
Background:
- Osteoarthritis (OA) research has utilized 'omics' technologies for over a decade.
- 'Omics' approaches analyze genes, proteins, and metabolites to understand disease mechanisms.
Purpose of the Study:
- To review recent 'omics' studies in osteoarthritis research.
- To discuss the conclusions and challenges of these studies.
- To highlight the potential of 'omics' for OA biomarker discovery.
Main Methods:
- Review of recent 'omics' literature in osteoarthritis.
- Analysis of findings related to OA pathogenesis.
- Identification of potential biomarker candidates.
Main Results:
- 'Omics' studies have significantly enhanced understanding of OA's pathogenic processes.
- Numerous molecules with potential biomarker utility for OA have been identified.
- 'Omics' data has provided insights into OA molecular mechanisms.
Conclusions:
- Extensive validation studies in large, well-characterized cohorts are necessary for clinical translation.
- Development of tools for integrating 'omics' data with clinical and imaging information is essential.
- Further research is needed to fully leverage 'omics' findings for OA patient benefit.